A new MRI sub-analysis of the STEP UP trial examined what 72 weeks of high-dose semaglutide (7.2 mg) does to body composition, including the thigh muscles. Fat loss was large, about 11 liters versus placebo, and fat infiltration within thigh muscle fell significantly. Thigh muscle volume dropped by about 1.1 L, a change that missed statistical significance (p = 0.07) but whose confidence interval leans toward loss. With only 55 scanned participants, just six on placebo, and Novo Nordisk involvement, the findings are suggestive rather than conclusive. Here's what the data show, what they can't, and how to protect your muscle on a GLP-1.
This page is available in